Lu, Yue
Ng, Alphonsus H. C.
Chow, Frances E. http://orcid.org/0000-0001-5402-2473
Everson, Richard G. http://orcid.org/0000-0003-2809-3061
Helmink, Beth A.
Tetzlaff, Michael T.
Thakur, Rohit
Wargo, Jennifer A. http://orcid.org/0000-0003-3438-7576
Cloughesy, Timothy F. http://orcid.org/0000-0002-8656-7483
Prins, Robert M. http://orcid.org/0000-0002-6282-6583
Heath, James R. http://orcid.org/0000-0001-5356-4385
Funding for this research was provided by:
Ben and Catherine Ivy Foundation
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P50CA211015, 1R01CA222695-01, U01 CA217655)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
The Parker Institute for Cancer Immunotherapy (PICI), the Andy Hill Cancer Research Endowment (CARE), the Brain Tumor Funder’s Collaborative, and the Cancer Research Institute (CRI).
Article History
Received: 23 September 2020
Accepted: 3 June 2021
First Online: 29 June 2021
Competing interests
: The authors declare no competing interests.